zepbound eli lilly news - Search News

Eli Lilly Will Sell Zepbound Through Telehealth Company Ro

Hosted on MSN · 20h

Eli Lilly Will Sell Zepbound Through Telehealth Company Ro in a Swipe at Legal Copycats

Amid new worries that legal copycats of the weight-loss drugs from Eli Lilly and Novo Nordisk could erode the market for the branded drugs, Lilly on Wednesday said it would sell a version of Zepbound through the telemedicine company Ro.

Business Insider · 22h

Ro, Eli Lilly to streamline patient access to Zepbound single-dose vials

Ro announced earlier that it is working with Eli Lilly (LLY) and Company to streamline access to Zepbound single-dose vials for Ro patients

Telehealth firm Ro to provide single-dose vials of Lilly's Zepbound to obesity patients

Telehealth company Ro said on Wednesday it will provide access to single-dose vials of Eli Lilly's weight-loss drug Zepbound to patients with obesity.

Eli Lilly to test weight loss drugs

NBC Los Angeles · 23h

Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly

It is made possible through a first-of-a-kind integration with Eli Lilly’s direct-to-consumer website, and aims to streamline access to the popular treatment.

Crain's New York · 3h

Eli Lilly taps Ro to help it sell a cheaper version of its weight-loss drug

Eli Lilly is partnering with the Flatiron-based telehealth company Ro to sell a cheaper version of its popular weight-loss drug directly to patients.

What can't weight-loss meds do? Eli Lilly is going to test Zepbound as a treatment for addiction

Eli Lilly (LLY), the pharma giant that produces the popular weight-loss drug Zepbound, said it plans to test the blockbuster drug as a treatment for alcohol and drug addiction starting next year.

23hon MSN

Eli Lilly is partnering with Ro to make it easier than ever to get Zepbound

Eli Lilly (LLY) has announced it will make lower-priced, single-dose vials of its popular weight-loss treatment Zepound ...

Eli Lilly strikes Zepbound deal with Ro, amid questions about future of compounded GLP-1s

Eli Lilly strikes Zepbound deal with the telehealth platform Ro, amid questions about future of compounded GLP-1s.

3d

Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now

Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results